Array BioPharma: FDA accepts New Drug Application for melanoma

Array BioPharma: FDA accepts New Drug Application for melanoma

BOULDER -- Array BioPharma (Nasdaq: ARRY) today announced the FDA has accepted its New Drug Application (NDA) for binimetinib with a target action date under the Prescription Drug User Fee Act... Read More

Thursday September 1, 2016 0 comments Tags: Boulder, Array BioPharma, binimetinib, Dr. Victor Sandor

Array BioPharma appoints industry veteran Victor Sandor as new chief medical officer

Array BioPharma appoints industry veteran Victor Sandor as new chief medical officer

BOULDER - Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on developing targeted small molecule drugs to treat cancer patients, announced the appointment of Victor... Read More

By: InnovatioNews Wednesday September 17, 2014 0 comments Tags: Array BioPharma, Boulder, Dr. Victor Sandor, Ron Squarer